OOIR: Observatory of International Research

Papers

(The TQCC of International Journal of Tuberculosis and Lung Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
The impact of COVID-19 on TB: a review of the data	162
Post-tuberculosis lung health: perspectives from the First International Symposium	101
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19	69
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	68
The Global Asthma Report 2022	53
Impact of COVID-19 on TB diagnosis in Northeastern Brazil	41
COVID-19 and tuberculosis—threats and opportunities	40
New diseases and old threats: lessons from tuberculosis for the COVID-19 response	39
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria	35
Impact of COVID-19 on tuberculosis control in China	32
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China	31
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review	29
Mask wearing to complement social distancing and save lives during COVID-19	29
Clinical standards for the diagnosis, treatment and prevention of TB infection	28
Post-TB health and wellbeing	28
The COVID-19 and TB syndemic: the way forward	26
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB	26
Post-tuberculosis sequelae: the need to look beyond treatment outcome	24
Clinical standards for the dosing and management of TB drugs	23
Severe COVID-19 cases with a history of active or latent tuberculosis	23
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis	22
Adapting TB services during the COVID-19 pandemic in Mumbai, India	22
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic	22
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function	22
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid	21

The burden and determinants of post-TB lung disease	21
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	20
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape	20
The need for pulmonary rehabilitation following tuberculosis treatment	19
Impact of COVID-19 on tuberculosis services in India	19
Thrombotic events and COVID-19 vaccines	19
Asbestos-related diseases	19
Impact of the global COVID-19 outbreak on the management of other communicable diseases	19
Critical changes to services for TB patients during the COVID-19 pandemic	18
TB and COVID-19 co-infection: rationale and aims of a global study	18
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	18
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic	18
How TB and COVID-19 compare: an opportunity to integrate both control programmes	18
Comparative analysis of Truenat™ MTB Plus and Xpert^® Ultra in diagnosing tuberculous meningitis	17
Resource reprioritisation amid competing health risks for TB and COVID-19	17
Mortality due to TB-COVID-19 coinfection in India	16
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment	16
Person-centred care in TB	16
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis	16
WHO drug-resistant TB guidelines 2022: what is new?	15
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms	15
Bedaquiline for multidrug-resistant TB in paediatric patients	15
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?	15
Chronic obstructive pulmonary disease in sub-Saharan Africa	15
Automated chest radiography and mass systematic screening for tuberculosis	15
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine	14
Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa	13
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	13
Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries	13
TB multimorbidity: a global health challenge demanding urgent attention	13
TB and the COVID-19 pandemic: brothers in arms against lung health	13
How to demystify COVID-19 and reduce social stigma	13
A randomised controlled trial to evaluate a medication monitoring system for TB treatment	13
Real-world implementation of video-observed therapy in an urban TB program in the United States	12
Determining the value of TB active case-finding: current evidence and methodological considerations	12
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini	12
Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes	11
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV	11
First molecular-based anti-TB drug resistance survey in Eritrea	11
UNITE4TB: a new consortium for clinical drug and regimen development for TB	11
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India	11
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning	11
Cost of TB services in healthcare facilities in Kenya (No 3)	10
Breastfeeding in women living with tuberculosis	10
The impact of PM2.5 on lung function in adults with asthma	10
Risk factors for chronic pulmonary aspergillosis in post-TB patients	10
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	10
How to manage children if a second wave of COVID-19 occurs	10
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression	10
The impact of COVID-19 on the diagnosis of TB in Taiwan	10

The scientific response to TB – the other deadly global health emergency	10
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives	10
Number needed to screen for TB in clinical, structural or occupational risk groups	10
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review	10
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis	10
Spatial variability in the risk of death from COVID-19 in Italy	10
Determinants of lung health across the life course in sub-Saharan Africa	10
Sustaining essential healthcare in Africa during the COVID-19 pandemic	10
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment	10
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil	10
First-line tuberculosis treatment with double-dose rifampicin is well tolerated	9
A comparison of digital chest radiography and Xpert^® MTB/RIF in active case finding for tuberculosis	9
A systematic review of the number needed to screen for active TB among people living with HIV	9
Modelling the potential impact of adherence technologies on tuberculosis in India	9
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB	9
Predictive models for COVID-19-related deaths and infections	9
VIDAS^® TB-IGRA reagents induce a CD4⁺ and CD8⁺ T-cell IFN-γ response for both TB infection and active TB	9
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam	9
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths	9
Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis	9
Vitamin D deficiency predicts latent TB reactivation independent of preventive therapy: a longitudinal study	9
The war in Ukraine and potential consequences for the TB epidemic in Europe	8
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing	8
Preparing national tuberculosis control programmes for COVID-19	8
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries	8
Opportunities to improve digital adherence technologies and TB care using human-centered design	8
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	8
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients	8
COPD exacerbation rates are higher in non-smoker patients in India	8
Impact of COVID-19 on patients with asthma	8
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis	8
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	8
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens	7
Concern over a COVID-19-related BCG shortage	7
Knowledge, attitudes and practices on childhood TB among healthcare workers	7
The economic burden of TB-affected households in DR Congo	7
Minimal clinically important difference of the 6-min walking test in patients with asthma	7
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men	7
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up	7
Treatment outcomes and safety in children with rifampicin-resistant TB	7
COVID-19: ensuring continuity of TB services in the private sector	7
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	7
Clinical standards for drug-susceptible pulmonary TB	7
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB	7
Outdoor air pollution and respiratory health	7
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease	7
Costs of TB services in India (No 1)	7
Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring	7
Country differences and determinants of yield in programmatic migrant TB screening in four European countries	7
Cost of TB services in the public and private sectors in Georgia (No 2)	7
Best practices for the care of pregnant people living with TB	7
QT prolongation in the STREAM Stage 1 Trial	7
Decreased notification of TB cases during the COVID-19 pandemic	6
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	6
Planning for TB elimination in Lebanon	6
An Inca trail to the Holy Grail: digital medication adherence support for TB care	6
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan	6
Work-related interstitial lung disease: what is the true burden?	6
Towards quality adolescent-friendly services in TB care	6
Post-TB bronchiectasis: from pathogenesis to rehabilitation	6
Impact of influenza A co-infection with COVID-19	6
Complications of tuberculous meningitis and their effect on outcome in a tertiary care cohort	6
A public health approach to increase treatment of latent TB among household contacts in Brazil	6
Vitamin D deficiency is associated with tuberculosis disease in British children	6
Global Asthma Report 2022: a wake-up call to enhance care and treatment for asthma globally	6
Xpert^® MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates	6
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City	6
High yields from contact investigation of child index TB patients	6
The diagnosis of lung cancer in the era of interventional pulmonology	6
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB	6
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	6
The Asthma Drug Facility and the future management of asthma	6
Continuity of TB services during the COVID-19 pandemic in China	6
Setting up pharmacovigilance based on available endTB Project data for bedaquiline	6
Key changes in the public health response to TB and HIV in South Africa	6
Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB	6
The effect of systematic screening of the general population on TB case notification rates	5
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus	5
A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB	5
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town	5
Density of cigarette retailers around educational facilities in Indonesia	5
Rapid development of a portable negative pressure procedural tent	5
The impact of COVID-19 on the TB response: data from the field	5
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19	5
Time for a change: considering regimen changes in analyses of observational drug-resistant TB treatment cohort data	5
TB in older people in Asia: why it is important	5
Face masks – a sustainable measure to mitigate COVID-19	5
Cost of TB services: approach and summary findings of a multi-country study (Value TB)	5
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	5
COVID-19 in Africa: community and digital technologies for tuberculosis management	5
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy	5
The 100^th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	5
Increase in disseminated TB during the COVID‐19 pandemic	5
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study	5
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB	5
Whole-genome sequencing differentiates relapse from re-infection in TB	5
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes	5
Clinical utility of target-based next-generation sequencing for drug-resistant TB	5
Patterns of suboptimal adherence among adolescents treated for tuberculosis	5
Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–2017	5
Using a mobile application to improve pediatric presumptive TB identification in western Kenya	5
Undernutrition can no longer be an afterthought for global efforts to eliminate TB	5
How mechanistic in silico modelling can improve our understanding of TB disease and treatment	5
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis	5
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study	5
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed	5
The impact of smoking on TB treatment outcomes includes recurrent TB	4
Effects of comorbidities on quality of life in Filipino people with tuberculosis	4
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients	4
Introducing new and repurposed TB drugs: the endTB experience	4
Systematic rifampicin resistance errors with Xpert^® MTB/RIF Ultra: implications for regulation of genotypic assays	4
Prevention care cascade in people exposed to drug-resistant TB	4
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan	4
Impact of lung function on treatment outcome in patients with TB	4
How much does TB screening cost? A systematic review of economic evaluations	4
COVID-19 and TB control in immigrant communities	4
Psychological distress among TB patients in sub-Saharan Africa	4
Screening for active and latent TB among migrants in France	4
Completion of treatment for latent TB infection in a low prevalence setting	4
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients	4
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era	4
COVID-19 and TB: a progression-regression conundrum	4
Adipokines and the risk of active TB: a nested case-control study	4
Post-TB disease: a new topic for investigation—and why it matters	4
Impact of COVID-19 on TB services in Korea	4
Seasonality, climate change and tuberculosis: new data and old lessons	4
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	4
The Bedaquiline Donation Program: progress and lessons learned after 4 years of implementation	4
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	4
Reference values of impulse oscillometry (IOS) for healthy Indian adults	4
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?	4
GPT-4, artificial intelligence and implications for publishing	4
Treatment success, but living with the consequences of post-tuberculosis sequelae	4
Helping Africa to breathe when COVID-19 strikes	4
Active case‐finding in contacts of people with TB	4
Reducing the burden of TB among migrants to low TB incidence countries	4
Tobacco use and quitting behaviour during COVID-19 lockdown	4
Incremental yield of Xpert^® MTB/RIF Ultra over Xpert^® MTB/RIF in the diagnosis of extrapulmonary TB	4
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis	4
Preventive treatment of drug-resistant TB in a rural setting	4
Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting	4
Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity	4
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens	4
Impact of the COVID-19 pandemic on TB infection testing	4
Sustained effect of isoniazid preventive therapy among household contacts in Brazil	4
Density of tobacco advertising around schools	4
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children	4
How Big Tobacco uses disruptive tactics to deny child rights to be tobacco-free	4
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes	4
Feasibility and acceptability of asynchronous VOT among patients with MDR-TB	3
Length of hospital stay for TB varies with comorbidity and hospital location	3
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	3
Diagnostic code agreement for electronic health records and claims data for tuberculosis	3
TB screening, prevention and treatment cascade in a Malawi prison	3
WHO target product profiles for TB preventive treatment	3
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	3
TB testing in HIV-positive patients prior to antiretroviral treatment	3
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis in China	3
Infection status of contacts is not associated with severity of TB in the index case	3
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali	3
Decline in TB incidence during the COVID-19 pandemic	3
High prevalence of pre-diabetes among people living with HIV in a high TB burden setting	3
Early mortality during rifampicin-resistant TB treatment	3
What to look for when using SUBsET for subnational TB incidence estimates	3
Digital approaches to reducing TB treatment loss to follow-up	3
Use of chest radiography screening for TB: a re-evaluation of the Kolín study	3
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	3
Digital adherence technology for TB: focus on livelihoods as well as lives	3
Diagnosis of paediatric TB using Xpert^® MTB/RIF Ultra on fresh respiratory samples	3
TB in ageing populations: lessons from Japan and Korea	3
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines	3